Skip to main content
MUSC
Education
Health
Research
MUSC Children's Health
Hollings Cancer Center
Careers
Giving
I want to
keyboard_arrow_down
Get Care
arrow_forward
Find a Program or Degree
arrow_forward
Explore Research
arrow_forward
Find a Job or Career Opportunity
arrow_forward
Access the Employee Portal
arrow_forward
Talk to Media Relations
arrow_forward
Give to MUSC
arrow_forward
About MUSC
arrow_forward
News & Events
Community Engagement
arrow_forward
Innovation
arrow_forward
arrow_back
Back
About MUSC
About MUSC
Administrative Offices
arrow_forward
Compliance
arrow_forward
Leadership
arrow_forward
Media Relations
arrow_forward
MUSC at a Glance
arrow_forward
Mission, Vision & Values
arrow_forward
Our Story
arrow_forward
Strategic Plan
arrow_forward
Visitor Support & Services
arrow_forward
arrow_back
Back
Community Engagement
Community Engagement
Funding & Economic Impact
arrow_forward
Health Equity
arrow_forward
Health Promotion
arrow_forward
In Our DNA
arrow_forward
MUSC Arboretum
arrow_forward
MUSC Women's Club
arrow_forward
Sustainability
arrow_forward
The Wellness Center
arrow_forward
arrow_back
Back
Innovation
Innovation
For MUSC Innovators
arrow_forward
Health Solutions
arrow_forward
Innovation District
arrow_forward
Strategic Partnerships
arrow_forward
arrow_back
Back
Quickly find what you need
arrow_back
Back
Thrombin, a blood-clotting protein, contributes to cancer growth by overpowering the immune system
By
Alhaji Harune Janneh
March 04, 2020
Share
Cancer Care +
Research
Share
Meet the Author
Alhaji Harune Janneh
Recent
Cancer Care
stories
Clinical Trials + Cancer Research
South Carolina strong: Fighting lung cancer through a clinical trial
Cancer Care + Patient Journeys
Neuroendocrine carcinoma patient balances work and treatment
Cancer Research + Impact
MUSC researchers enhance smoking cessation treatment for people living with HIV
See All Cancer Care Stories
